From cell surface to the nucleus, a short but critical journey for retroviruses

From the cell surface to the nucleus, retroviruses will face multiple obstacles, crossing physical barriers such as the plasma membrane, but also finding their pathway through a viscous cytoplasm. At the same time, retroviruses have to overcome cellular defenses, interfering with the early steps of the virus life cycle. Although the general outcomes of this journey have been known for several decades, the stepwise interactions taking place between cellular and viral factors, which will transform the incoming viral RNA genome into a double-stranded DNA competent for integration, remain largely unknown. In this sense, the uncoating process and the molecular basis of intracellular trafficking of preintegration complexes are still poorly defined. Additionally, other key stages, which have been the focus of many reports, still require some clarification, as is the case for the precise implication of viral and cellular determinants involved in nuclear import of preintegration complexes.

[1]  Joseph Sodroski,et al.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Berro,et al.  Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin , 2006, Retrovirology.

[3]  Michael Emerman,et al.  Retroviral infection of non-dividing cells: old and new perspectives. , 2006, Virology.

[4]  Lucy A. Perrone,et al.  Interaction of Moloney Murine Leukemia Virus Capsid with Ubc9 and PIASy Mediates SUMO-1 Addition Required Early in Infection , 2006, Journal of Virology.

[5]  Paul Shinn,et al.  A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.

[6]  M. Emerman,et al.  The Cell Cycle Independence of HIV Infections Is Not Determined by Known Karyophilic Viral Elements , 2005, PLoS pathogens.

[7]  S. Nisole,et al.  TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.

[8]  A. Saïb,et al.  Protease-Dependent Uncoating of a Complex Retrovirus , 2005, Journal of Virology.

[9]  P. Puthavathana,et al.  Uncoating of HIV-1 requires cellular activation. , 2005, Virology.

[10]  R. Benarous,et al.  The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding* , 2005, Journal of Biological Chemistry.

[11]  W. Greene,et al.  Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells , 2005, Nature.

[12]  S. Le,et al.  Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. , 2005, Immunity.

[13]  Pierre Baldi,et al.  Retroviruses and yeast retrotransposons use overlapping sets of host genes. , 2005, Genome research.

[14]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[15]  A. Skalka,et al.  Effects of cell cycle status on early events in retroviral replication , 2005, Journal of cellular biochemistry.

[16]  D. Pérez-Caballero,et al.  Cyclophilin Interactions with Incoming Human Immunodeficiency Virus Type 1 Capsids with Opposing Effects on Infectivity in Human Cells , 2005, Journal of Virology.

[17]  S. Goff Retrovirus restriction factors. , 2004, Molecular cell.

[18]  Jeremy Luban,et al.  Target Cell Cyclophilin A Modulates Human Immunodeficiency Virus Type 1 Infectivity , 2004, Journal of Virology.

[19]  S. Nisole,et al.  A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Sodroski,et al.  TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Yang,et al.  Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Nisole,et al.  Trim5α protein restricts both HIV-1 and murine leukemia virus , 2004 .

[23]  J. Luban,et al.  Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1 , 2004, Nature.

[24]  Marc C. Johnson,et al.  The stoichiometry of Gag protein in HIV-1 , 2004, Nature Structural &Molecular Biology.

[25]  T. Hope,et al.  Disruption of the Actin Cytoskeleton Can Complement the Ability of Nef To Enhance Human Immunodeficiency Virus Type 1 Infectivity , 2004, Journal of Virology.

[26]  S. Nisole,et al.  Early steps of retrovirus replicative cycle , 2004, Retrovirology.

[27]  C. M. Owens,et al.  The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys , 2004, Nature.

[28]  P. Bieniasz,et al.  Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors , 2003, Nature Medicine.

[29]  E. Réal,et al.  Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8 , 2003, Journal of Cell Science.

[30]  D. McDonald,et al.  Visualization of the intracellular behavior of HIV in living cells , 2002, The Journal of cell biology.

[31]  A. Skalka,et al.  Transduction of Interphase Cells by Avian Sarcoma Virus , 2002, Journal of Virology.

[32]  S. Goff Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways , 2001, The journal of gene medicine.

[33]  L. Dixon,et al.  African Swine Fever Virus Protein p54 Interacts with the Microtubular Motor Complex through Direct Binding to Light-Chain Dynein , 2001, Journal of Virology.

[34]  S. Goff,et al.  Infection of Nondividing Cells by Rous Sarcoma Virus , 2001, Journal of Virology.

[35]  D. Trono,et al.  Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. , 2001, Molecular cell.

[36]  M. Way,et al.  Viral transport and the cytoskeleton , 2001, Current Opinion in Cell Biology.

[37]  F. Bushman,et al.  Retroviral cDNA Integration: Stimulation by HMG I Family Proteins , 2000, Journal of Virology.

[38]  N. Tordo,et al.  Cytoplasmic Dynein LC8 Interacts with Lyssavirus Phosphoprotein , 2000, Journal of Virology.

[39]  A. Saïb,et al.  Foamy viruses: between retroviruses and pararetroviruses. , 2000, Virology.

[40]  S. King,et al.  The molecular anatomy of dynein. , 2000, Essays in biochemistry.

[41]  C. Desgranges,et al.  Identification of Three Major Phosphorylation Sites within HIV-1 Capsid , 1999, The Journal of Biological Chemistry.

[42]  M. Stevenson,et al.  Establishment of a Functional Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcription Complex Involves the Cytoskeleton , 1998, The Journal of experimental medicine.

[43]  Bertrand Friguet,et al.  Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[44]  M. Linial,et al.  Human Foamy Virus Replication: A Pathway Distinct from That of Retroviruses and Hepadnaviruses , 1996, Science.

[45]  L. Menéndez-Arias,et al.  Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase. , 1995, Journal of cell science.

[46]  J. Sodroski,et al.  Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.

[47]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[48]  Jeremy Luban,et al.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.

[49]  P. Brown,et al.  Integration of murine leukemia virus DNA depends on mitosis. , 1993, The EMBO journal.

[50]  M. Bukrinsky,et al.  Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Malim,et al.  Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes , 1991, The Journal of experimental medicine.